Back
Protagonist Therapeutics Vs. Transcat Industry Stock Comparison
Buy
56
PTGX
Protagonist Therapeutics
Last Price:
33.37
Seasonality Move:
14.81%
Buy
62
TRNS
Transcat
Last Price:
121.40
Seasonality Move:
5.39%
Buy
56
Protagonist Therapeutics (PTGX)
is a Buy
Is Protagonist Therapeutics a Buy, Sell or Hold?
- The current Protagonist Therapeutics [PTGX] share price is $33.39. The Score for PTGX is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
- PTGX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
62
Transcat (TRNS)
is a Buy
Is Transcat a Buy, Sell or Hold?
- The current Transcat [TRNS] share price is $121.59. The Score for TRNS is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
- TRNS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
PTGX Stock Price Chart
What is Protagonist Therapeutics's stock price today?
-
The Protagonist Therapeutics share price today is $33.39
The current trend is moderately bullish and PTGX is experiencing slight selling pressure.
TRNS Stock Price Chart
PTGX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.48 | Buy |
| Relative Strength Index (14 RSI): | 60.08 | Buy |
| Chaikin Money Flow: | -119501 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (29.07 - 33.45) | Buy |
| Bollinger Bands (100): | (26 - 31.02) | Buy |
TRNS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.19 | Buy |
| Relative Strength Index (14 RSI): | 45.27 | Sell |
| Chaikin Money Flow: | 11200 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (120.29 - 133.09) | Sell |
| Bollinger Bands (100): | (104.3 - 122.26) | Buy |
PTGX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 33.96 | Sell |
| 20-day SMA: | 31.55 | Buy |
| 50-day SMA: | 28.85 | Buy |
| 200-day SMA: | 23.59 | Buy |
| 8-day EMA: | 33.27 | Buy |
| 20-day EMA: | 31.77 | Buy |
| 50-day EMA: | 29.87 | Buy |
| 200-day EMA: | 25.42 | Buy |
TRNS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 125.83 | Sell |
| 20-day SMA: | 128.56 | Sell |
| 50-day SMA: | 118.56 | Buy |
| 200-day SMA: | 106.03 | Buy |
| 8-day EMA: | 124.88 | Sell |
| 20-day EMA: | 125.15 | Sell |
| 50-day EMA: | 120.46 | Buy |
| 200-day EMA: | 107.38 | Buy |
Protagonist Therapeutics Earnings Growth & PTGX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, an increase next quarter of $2.69 per share, an increase this year of $4.32 per share, and a decrease next year of $2.45 per share.
Transcat Earnings Growth & TRNS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.25 per share, an increase next quarter of $0.27 per share, an increase this year of $0.68 per share, and an increase next year of $0.59 per share.
Protagonist Therapeutics Technical Analysis
| Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 03 | 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Transcat Technical Analysis
| Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 03 | 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||